Monitor for any related district-court or ITC litigation involving this patent that could affect Palo Alto Networks. The denial is procedural, so the patent owner retains the right to assert the patent in other forums.
How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+1- T+0 · Nov 10 $326.36entry
- T+1 · 6d ago +2.48%α +1.17% · $334.47
- T+4 · todayOpen
- T+5 · in 3h Pending
- T+20 · in 22d Pending
- T+60 · in 3mo Pending
Price Chart
REPLAYWatch the reaction play outExecutive Summary
The PTAB denied institution of inter partes review in IPR2026-00431 on discretionary grounds, meaning Palo Alto Networks' challenge to Qomplx LLC's patent covering network event anomaly correlation was not granted a trial. The challenged patent claims remain in force, but the denial is procedural and does not address the merits of the patent's validity.
PTAB Trial Details
Key Facts
- IPR2026-00431 was denied institution on discretionary grounds under 35 U.S.C. § 314(a).
- The patent at issue is U.S. 12301627, titled 'Correlating Network Event Anomalies Using Active and Passive External Reconnaissance to Identify Attack Information'.
- Patent owner is Qomplx LLC; petitioner is Palo Alto Networks, Inc.
- The decision is a Director discretionary denial, not a merits-based ruling.
- No claims were cancelled or held unpatentable; the patent remains in force.
Financial Impact
No financial impact stated in the decision; the patent is not tied to any named Palo Alto product or revenue line.
Risk Factors
- The patent remains enforceable and could be asserted against Palo Alto Networks in district court or at the ITC.
- No merits determination was made, so the patent's validity has not been tested.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 PTAB decision.
| Document | Accession Number |
|---|---|
| PTAB-TRIAL Data (Synthetic) | ptab-IPR2026-00431-den-PANW |
Track record
32 reports on PANW
6 of 8 bullish or bearish reports moved the stock their way by T+20. Best: +89.89% at T+60 after the Mar 27, 2026 report. 7 of 10 went positive at some point.
Filters
- Nov 10, 20267d ago PTAB Trial Neutral 2/10 Viewing Entry $326.36 Now $316.09 −3.15% settles Dec 9
- Nov 10, 20267d ago PTAB Trial Neutral 2/10 Entry $326.36 Now $316.09 −3.15% settles Dec 9
- Nov 4, 202612d ago 144 Neutral 2/10 Entry $314.67 Now $316.09 +0.45% settles Dec 4
- Nov 3, 202613d ago 144 Neutral 2/10 Entry $348.04 Now $316.09 −9.18% settles Dec 3
- Nov 2, 202614d ago 144 Neutral 3/10 Entry $350.20 Now $316.09 −9.74% settles Dec 2
- Oct 30, 202617d ago Press Release Neutral 2/10 Entry $365.87 Now $316.09 −13.61% settles Nov 30
- Oct 29, 202619d ago Court Ruling Bearish 4/10 Entry $365.87 Now $316.09 +13.61% settles Nov 30
- Oct 27, 202620d ago DEFA14A Neutral 3/10 Entry $394.49 Now $316.09 −19.87% settles Nov 25
- Oct 27, 202620d ago DEF 14A Neutral 4/10 Entry $394.49 Now $316.09 −19.87% settles Nov 25
- Oct 20, 202627d ago Institutional Cluster Bearish 4/10 Entry $347.25 Now $316.09 +8.97% settles Nov 18
US Market Status
Subscribe to SecBot
Get Real-Time PTAB Decision Intelligence
Market-moving PTAB patent decisions analyzed within minutes. Trial institutions, denials, final written decisions, and more, parsed and scored by AI.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers